Dianthus Therapeutics, Inc. (DNTH) Total liabilities 2017–2025
Dianthus Therapeutics, Inc. (DNTH) total liabilities at each fiscal year-end, per SEC filings.
$37.5MFY2025 · since FY2017: $4.1M → $37.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $37.5M | +74.3% |
| FY2024 | $21.5M | +104.4% |
| FY2023 | $10.5M | +11.4% |
| FY2022 | $9.5M | +76.6% |
| FY2021 | $5.4M | — |
| FY2019 | $20.3M | +74.2% |
| FY2018 | $11.7M | +181.6% |
| FY2017 | $4.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice